The anti-apoptotic protein, BAX inhibitor-1 (BI-1), has a role in cancer/tumor progression. BI-1-overexpressing HT1080 and B16F10 cells produced higher lung weights and tumor volumes after injection into the tail veins of mice. Transfection of BI-1 siRNA into cells before injection blocked lung metastasis. in vitro, the overexpression of BI-1 increased cell mobility and invasiveness, with highly increased glucose consumption and cytosolic accumulation of lactate and pyruvate, but decreased mitochondrial O 2 consumption and ATP production. Glucose metabolism-associated extracellular pH also decreased as cells excreted more H þ , and sodium hydrogen exchanger (NHE) activity increased, probably as a homeostatic mechanism for intracellular pH. These alterations activated MMP 2/9 and cell mobility and invasiveness, which were reversed by the NHE inhibitor, 5-(N-ethyl-N-isopropyl) amiloride (EIPA), suggesting a role for NHE in cancer metastasis. In both in vitro and in vivo experiments, C-terminal deleted (CDBI-1) cells showed similar results to control cells, suggesting that the C-terminal motif is required for BI-1-associated alterations of glucose metabolism, NHE activation and cancer metastasis. These findings strongly suggest that BI-1 reduces extracellular pH and regulates metastasis by altering glucose metabolism and activating NHE, with the C-terminal tail having a pivotal role in these processes.
Introduction
Most tumors/cancers develop a pathophysiological microenvironment characterized by hypoxic conditions, including low oxygen tension and elevated interstitial fluid pressure (Rofstad et al., 2006) . Alterations of glucose metabolism regulate cancer metastasis by high glucose uptake, high lactate formation, low extracellular pH (pH e ) and reduction of intratumoral pH (Bhujwalla et al., 2002; Schornack and Gillies, 2003; Gatenby and Gillies, 2004; Gatenby et al., 2006) . The acidic environment is produced by the activity of ion channels and transporters such as Na þ /H þ or Cl/HCO 3 exchangers (Klein et al., 2000; Saadoun et al., 2005) . The ubiquitously expressed Na þ /H þ exchanger isoform, sodium hydrogen exchanger (NHE1), also contributes to this acidic environment (Plopper et al., 1995) . NHE1 activity is important for many tumor cells (Lagarde et al., 1988; Rotin et al., 1989; McLean et al., 2000) . Insufficient and/ or inefficient tumor vascularization leads to diminished O 2 supply so that tumor cell metabolism is mostly glycolytic (Helmlinger et al., 2002) . Thus, tumor cells are often challenged by an increased acid load (Griffiths, 1991) . The excess protons are extruded into the extracellular space by transport proteins such as NHE1 (Wahl et al., 2000) , which then causes acidification of the extracellular space . NHE activation enhances the invasiveness of human breast carcinoma cells (Reshkin et al., 2000) , implying the involvement of NHE and pH e in metastasis and tumor malignancy. However, the factors that decrease pH e in tumor cell metastasis are still unclear.
The anti-apoptotic protein, Bax inhibitor-1 (BI-1), was identified through a functional screen in yeast designed to select for human cDNAs that inhibit Baxinduced apoptosis (Xu and Reed, 1998) . BI-1 regulates Ca 2 þ concentrations in the endoplasmic reticulum and cytosol in a pH-dependent manner (Kim et al., 2008) through a motif in the C terminus, EKDKKKEKK. The anti-apoptotic function of BI-1 contributes to the development of cancer and the resistance to antitumor therapies (Igney and Krammer, 2002; Grzmil et al., 2003 Grzmil et al., , 2006 . In fact, the expression of BI-1 is upregulated in human breast cancer cells (Igney and Krammer, 2002) , prostate cancer (Grzmil et al., 2006) and cervical cancer (Harima et al., 2004) . However, the exact roles of BI-1 in cancer progression remain unknown.
Here, we investigated the roles of BI-1 in cancer development/progression in vitro and in vivo. Our results reveal that BI-1 affects cancer progression by altering glucose metabolism and NHE activation.
Results

BI-1 promotes cancer metastasis in vivo
To examine whether BI-1 is linked to cancer progression in vivo, human carcinoma HT1080 cells were stably transfected with the cDNA of a neomycin-resistant vector (Neo), wild-type BI-1 (BI-1) or a C-terminaldeleted BI-1 mutant (CDBI-1) and were injected into the tail vein of nude mice. BI-1 expression was confirmed before injection of cells into the tail vein (Figure 1a, upper) . After 4 weeks, lung metastasis increased in BI-1 cell-injected mice ( Figure 1a ) with lung weight and tumor volume significantly increased in BI-1 cell-injected mice (Figures 1b and c) . In contrast, lung weight and tumor volume from mice injected with CDBI-1 cells were similar to lungs of mice injected with Neo cells (Figures 1b and  c ). Mice injected with Neo and BI-1-transfected B16F10 melanoma cells showed increased numbers of lung nodules, but not CDBI-1 transfectants (Figures 1d and  e) . Similarly, mice injected with B16F10 cells expressing an HA-N-terminal-tagged-BI-1, as opposed to the C-terminal-tagged construct used above, showed highly metastatic phenotypes and increased nodule numbers ( Supplementary Figures 1a and b) . These data suggest that the upregulation of BI-1 expression leads to cancer metastasis, and that the C-terminal motif is required for this process. Knockdown of BI-1 expression with BI-1 siRNA in this model reduced BI-1 expression and blocked cancer metastasis into the lung by both BI-1 and Neo cells (Figure 1f ). Lung weight was significantly decreased in BI-1 siRNA-transfected BI-1 cells, but not in Neo cells (Figure 1g ). BI-1 siRNA also decreased tumor volume, another marker for cancer metastasis (Figure 1h ). Thus, BI-1 influences cancer metastasis.
Overexpression of BI-1 increases cell motility and invasiveness The invasive potential of HT1080 cells expressing BI-1 and CDBI-1 (Figure 2a , upper panel) was determined using a matrigel chamber assay. The penetration of BI-1 cells was fourfold higher than that of Neo or CDBI-1 cells (Figure 2a ). Wound migration analyses also showed that BI-1 cells had significantly increased mobility compared with Neo and CDBI-1 cells (Figure 2b ). Cells were pretreated with mitomycin C before an injury line was made to rule out any effect on cell proliferation . Neo and BI-1 cells were cultured from subconfluency (o70%) and the total cell number was counted on days 1, 2 and 3. Cell proliferation was similar at 24 h ( Supplementary  Figure 2) , but BI-1 cells showed decreased proliferation at longer time points, ruling out an effect of cell proliferation. Reducing BI-1 expression using siRNA also attenuated this invasiveness ( Figure 2c ) and cell motility (Figure 2d ). These data suggest that BI-1 promotes invasiveness and motility of cancer cells through its C-terminal motif.
Overexpression of BI-1 enhances glycolysis
Increased glycolysis is a phenotypic trait almost invariably observed in human cancers that confers a selective growth advantage on transformed cells by creating an acidic environment toxic to competitors but is relatively harmless to themselves (Schornack and Gillies, 2003; Rofstad et al., 2006) . The rates of glucose consumption ( Figure 3a ) and lactate formation (Figure 3b ) in BI-1 cells were significantly greater than those in Neo and CDBI-1 cells. In cancer cells, cytoplasmic pyruvate accumulates due to decreases in mitochondrial metabolism (Lu et al., 2008) . Cytoplasmic pyruvate levels in BI-1 cells were higher than in Neo and CDBI-1 cells (Figure 3c ). Pyruvate dehydrogenase has a fundamental role in mitochondrial bioenergetics, and it is the entry point of carbohydrates into the tricarboxylic acid cycle in the form of acetyl-CoA units (Stacpoole et al., 2003; Stephens et al., 2007) . The proportion of pyruvate dehydrogenase (PDH) in the active form (PDH1a) was reduced significantly in BI-1 cells compared with Neo cells (Figure 3d ). Consistently, PDH activity was significantly reduced in BI-1 cells (Figure 3e ). The level of mitochondrial ATP in BI-1 cells was also significantly lower than in Neo and CDBI-1 cells, but the total ATP level was not different (Figure 3f ). Oxygen consumption, which is required to oxidize NADH or FADH 2 (Thomas et al., 2008) , was significantly lower in BI-1 cells than in Neo and CDBI-1 cells (Figure 3g ). In contrast, glycolytic flux was higher as shown by increased glucose consumption and lactic acid production (Figures 3a and b) . In BI-1 cells, mitochondrial ultrastructure showed cristae and matrix densities (Supplementary Figure 3a) , and mitochondria were larger (Supplementary Figure 3b) , indicating alterations in mitochondrial function. These results suggest that BI-1 cells shift their energy metabolism toward glycolysis to generate their ATP supply.
BI-1 decreases extracellular pH
In the glucose metabolism pathway, glucose is a major source of H þ , as it is metabolized into lactate and H þ (Provent et al., 2007) . The rate of H þ production increased on the basis of glucose concentration and was significantly higher in BI-1 cells than in Neo cells and CDBI-1 cells (Figure 4a) , as shown by changes in phenol red medium (Supplementary Figure 4) . The pH of cell culture media (pH e ) of BI-1 cells was significantly lower than that of Neo and CDBI-1 cells (Figure 4b ), and BI-1 cells showed a higher pH dependency on glucose concentrations (Figure 4c ). After incubation for 12, 24, 36 or 48 h, BI-1 cells showed higher activity of the acidsensitive matrix metalloproteinase-2/9 (MMP2/9) than did Neo or CDBI-1 cells (Figure 4d ). BI-1 silencing blocked this increase in MMP2/9 activity (Figure 4e protons are extruded by the NHE, which causes extracellular acidification. We studied the impact of extra/intra cellular pH and NHE activity on BI-1-induced cancer metastasis in vitro. However, the NHE1 mRNA level was similar in Neo, BI-1 and CDBI-1 cells (Figure 5a ). NHE2 and 3 mRNA levels were also similar (data not shown). However, BI-1 cells, but not CDBI-1 cells, showed high NHE activity (Figure 5b ), indicating functional activation, probably due to increased intracellular H þ . NHE could be strongly inhibited by 5-(Nethyl-N-isopropyl) amiloride (EIPA, an inhibitor of NHE1) in BI-1 cells (Figure 5c ). NHE extrudes H þ through intrusion of Na þ to regulate intracellular pH (Plopper et al., 1995; Klein et al., 2000) . To understand the physiological meaning of NHE1 in BI-1 cells, intraand extracellular pH were measured in Neo, BI-1 and CDBI-1 cells with or without EIPA. In BI-1 cells, intracellular pH decreased, but extracellular pH increased up to pH 6.8 (Figure 5d ). However, in Neo and CDBI-1 cells, the time-kinetic slope of intra-and extracellular pH is modest compared with BI-1 cells. EIPA treatment dose-dependently showed the regulatory effect in intra-and extracellular pH in BI-1 cells ( Supplementary Figures 6a and b) . EIPA treatment also reduced the invasiveness and mobility of BI-1 cells (Figures 5e and f). NHE1 inhibition decreased MMP2/9 activity in Neo, BI-1 and CDBI-1 cells (Figure 5g ). Dimethyl amiloride, another specific NHE1 inhibitor, also regulated two metastasis markers: invasiveness and mobility in BI-1 cells (Figures 5h and i) . CDBI-1 and Walz, 2007). HOE694 (NHE2 inhibitor) and S 3226 (NHE3 inhibitor) also inhibited cell motility and invasiveness more significantly in BI-1 cells than did Neo and CDBI-1 cells (data not shown).
Discussion
Here, we identify a role for BI-1 in cancer progression in vitro and animal models. BI-1 is involved in the upregulation of glucose uptake, downregulation of PDH activity, and accumulation of lactate, creating an acidic environment or Warburg effect, which describes the propensity of most cancer cells to avidly take up glucose and convert it primarily to lactate, despite the available oxygen (Deberardinis et al., 2008; Kroemer and Pouyssegur, 2008) . Alterations in mitochondrial glucose metabolism produce acidic environments and cancer metastasis in other systems, too (Chen et al., 2007) . As BI-1 can inhibit mitochondrial glucose metabolism (Figure 3 ), low O 2 consumption in BI-1 cells may relate to BI-1-induced cell protection, which may explain why BI-1 cells are less susceptible than control cells to ischemia or oxygen/glucose deprivation (Chae et al., 2004; Dohm et al., 2006) . BI-1-knockdown approaches, including knockout mice or siRNA, show that BI-1 contributes to the resistance against infarction or sucrose starvation (Bolduc and Brisson, 2002; Chae et al., 2004) . Here, BI-1 cells used inefficient glycolytic pathways, leading to acidic extracellular pH (Figures 4b and c) . Although the expression of BI-1 does not increase cell proliferation (Supplementary Figure 2) , the extracellular pH becomes more acidic in BI-1 cells than in control cells, suggesting that glucose metabolism is altered. Longer culture periods may allow equalization of extracellular pH in Neo and BI-1 cells, but BI-1 cells die because of the severely acidic medium and excess glucose consumption (data not shown). In this study, BI-1 actively shunts pyruvate away from the mitochondria by decreasing PDH activity and enhancing the conversion of pyruvate to lactate and hydrogen ions (H þ ), causing low oxygen consumption (Figures 3b-g ). Even modest reductions in PDH activity can lead to accumulation of pyruvate, lactic acid and intracellular hydrogen ions (H þ ) (Stellingwerff et al., 2003) . Increased intracellular H þ can affect the pH-homeostasis system, including NHE. Functionally activated NHE correlated with the amount of H þ extrusion (Figures 4b and 5b) . In the presence of NHE1 inhibitor, cell viability was significantly lower in BI-1 cells than in Neo cells, showing that intracellular pH was more acidic (o pH 6.4) in BI-1 cells than in Neo cells (data not shown). Thus, NHE activity in BI-1 cells rescued the cells from the acidic intracellular environment through the extrusion of H þ . Furthermore, the accumulation of extracellular H þ leads to cancer metastasis in BI-1 cells. Hydrogen ions (H þ ) have a major role in many normal cellular processes, including the control of tumorigenic processes such as oncogenesis, oncogene expression and malignant transformation (Putney et al., 2002 , Harguindey et al., 2005 . The ability to secrete protons is dependent on membrane-localized ion exchangers such as NHEs, Na þ -dependent and independent HCO 3 þ /Cl À exchangers, and the H þ /lactate cotransporter. Acidic pHi and oncogenic transformation activate NHE1, thereby creating an acidic extracellular microenvironment (Kaplan and Boron, 1994, Reshkin et al., 2000) . Overactive NHE1 provides tumor cells a twofold advantage: (i) a favorable alkaline pHi (up to pHi 7.6) for a variety of metabolic processes and (ii) an acidic pHe enhances the invasive capability of tumor cells, whereas normal cells rapidly die in an acidic environment. NHE1 also has a role in facilitating tumor cell motility and invasion through regulation of the actin cytoskeleton and integrin function (Steffan et al., 2009) .
In cancer cells, high NHE1 expression indicates a homeostatic mechanism for intracellular pH (Bourguignon et al., 2004) . It is required for the migration of keratinocytes (Bereiter-Hahn and Voth, 1988), neutrophil granulocytes (Rosengren et al., 1994) , fibroblasts and renal epithelial cells (Klein et al., 2000) . NHE inhibition reduces the migration rate of MDCK-F cells (Klein et al., 2000) , whereas NHE activation augments the motility and the invasiveness of human breast carcinoma cells (Reshkin et al. 2000) . Interestingly, the NHE and integrin receptor molecules are often colocalized at the focal adhesion sites of the leading edges of lamellipodia (Grinstein et al., 1993; Plopper et al., 1995) . Thus, NHE could create a proton-enriched microenvironment in the immediate vicinity of the focal adhesion complexes, that is, close to integrin molecules. The critical pathologic turning point in cancer is the initiation of local invasion leading to the dissemination of tumor cells. Invasion is an active translocation of neoplastic cells across tissue boundaries through host cellular and extracellular matrix barriers (Westermarck and Kahari, 1999; Jones et al., 2004) . MMP2/9, a tumor invasion signaling protein, was significantly increased in BI-1 cells (Figure 4d ). In high glucose media, MMP activity showed a time-dependent increase that correlated with decreases in pH e (Figures 4c and d) . Most invasive colonic, gastric, breast and ovarian carcinomas have high expression of MMPs, especially MMP-2 and MMP-9 (Boyd and Balkwill, 1999) . The evidence for MMPs as active contributors to cancer progression comes from animal studies (Schmalfeldt et al., 2001) . Furthermore, acidic media (pH 5.4-6.5) increases MMP activity in cell culture (Rofstad et al., 2006) . Overall, the expression of these enzymes correlates with tumor aggressiveness (Westermarck and Kahari, 1999; Jones et al., 2004) . Despite several studies of BI-1 in cancer (Grzmil et al., 2003 (Grzmil et al., , 2006 Harima et al., 2004) , its role is still unclear. In breast cancer cells, BI-1 levels are regulated by tamoxifen (Del Carmen et al., 2005) . BI-1 also prevented certain breast cancer cells from undergoing apoptosis, explaining the role of BI-1 as a cancerassociated protein against apoptotic stimuli (Grzmil et al., 2006) . Consistently, we found that lymph node metastasis in non-small cell lung carcinoma patients correlated with immunostaining of BI-1 (data not shown).
In conclusion, BI-1 influences cancer metastasis. BI-1 reduces extracellular pH and regulates metastasis by altering glucose metabolism and NHE activation. Further understanding of the critical role of the acidic tumor-host interface will allow the development of novel tumor therapy strategies based on perturbations of the acidic environment. * * Daejeon, Korea) . Throughout the experiments, mice were maintained with free access to pellet food and water in plastic cages at 21 ± 2 1C and kept on a 12-h light-dark cycle. Animal welfare and experimental procedures were performed strictly in accordance with the care and use of laboratory animals (Chonbuk National University IACUC, Jeonju, Korea) and the related ethics regulations of our university. All efforts were made to minimize animal suffering and to reduce the number of animals used.
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Materials and methods
Materials
Cell culture
Human HT1080 fibrosarcoma and B16F10 melanoma cells were cultured in DMEM supplemented with 10% fetal bovine serum, 20 mM HEPES, 100 mg/ml streptomycin and 100 units/ ml penicillin. The cells were stably transfected with the pcDNA3 (Neo), pcDNA3-BI-1-HA or C-BI-1-HA (C-terminal-deleted) plasmids using the Superfect transfection reagent (Qiagen, Hilden, Germany). The cells were then cultured for 3 weeks in 1 mg/ml G418 (Invitrogen, Carlsbad, CA, USA).
Metastasis experiments in vivo
For production of lung metastasis, HT1080 cells (5 Â 10 6 cells) suspended in 0.2 ml of phosphate-buffered saline were injected into nude mice through the tail vein. B16F10 cells (5 Â 10 6 cells) suspended in 0.2 ml of phosphate-buffered saline were injected into SCI mice through the tail vein. After injection, mice were humanely killed on day 28 and lung weight and tumor volume was determined.
Immunoblotting
Cell lysates were prepared and the level of protein expression was measured as described elsewhere (Kim et al., 2008 ). An equal amount of protein extracted from cells with RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 2 mM sodium fluoride, 2 mM EDTA, 0.1% SDS and protease inhibitor cocktail) was separated on a 10% SDS-PAGE gel. The proteins were transferred to nitrocellulose membranes. After each membrane was probed with a specific primary antibody (1:1000 for HA, MMP-2 and MMP-9 antibodies), the blot was stripped and re-probed with a polyclonal antibody against b-actin (Santa Cruz, CA, USA) to confirm equal protein loading and transfer. An enhanced chemiluminescence (ECL, Amersham-Pharmacia, Buckinghamshire, UK) system was used for protein detection.
Invasion assay
The in vitro invasion assay was performed in 24-well transwell plates with polycarbonate membranes (Corning Costar, Cambridge, MA, USA) as previously described . The bottom of the chamber was coated with type I collagen, and the top was coated with matrigel (Collaborative Research, Lexington, KY, USA). The lower chamber was filled with serum-free medium containing 0.1% BSA. Cells were placed in the upper chamber incubated for 17 h, fixed with methanol, and stained with hematoxylin and eosin for 10 min. The invasive phenotypes were determined by counting the cells that migrated to the lower side of the membrane under a microscope. Thirteen fields were counted for each membrane, and each sample was assayed in triplicate.
Wound migration assay Cells were pretreated with mitomycin C (25 mg/ml) 30 min before an injury line was made. The injury line was made with a tip 2 mm wide on cells plated in culture dishes at 90% confluency. After being rinsed with phosphate-buffered saline, cells were allowed to migrate in complete medium, and photographs were taken ( Â 40).
Lactate production and glucose consumption Lactate production and glucose consumption rates were determined in cells grown to confluence in 24-well plates (Falcon, model 3047; Becton Dickinson, Franklin Lakes, NJ, USA). Cells were inoculated at a density of 1 Â 10 4 cells per well and allowed to grow for 3 to 4 days until confluent. Lactate and glucose levels were measured by commercial kits from BioVision (Mountain View, CA, USA).
Proton production rates
Proton production rates were measured by monitoring the optical absorbance of phenol red at 450 and 562 nm in the buffer solution on cell monolayers in 96-well plates, as previously described (Gillies et al., 1990 , Bennett et al., 1982 . The change in absorbance spectra of phenol red was reciprocal between pH 6 and pH 10 at 450 and 562 nm. The ratio of absorbance at 562/450 nm can be used to generate a titration curve (data not shown) that can be fitted by: pH ¼ 7.2 þ log(11.5-R)/(R) þ log(0.38), where 11.5 is the ratio at high pH and 0.38 is a correction factor representing the ratio of absorbance at high to low pH at the denominator wavelength (450 nm). The reliability of this method shows a good correlation (r 2 40.99) between the pH measured by phenol red and by electrode in the pH range 6.0 to 7.5 (data not shown).
Measurement of cellular O 2 consumption
Cells were trypsinized and suspended at 3-8 Â 10 6 cells per ml in DMEM containing 10% FBS and 25 mM HEPES. For each experiment, equal numbers of cells suspended in 0.4 ml NHE has an important role in BI-1-induced metastasis. Neo, BI-1 and CDBI-1 cells were incubated with high glucose medium (20 mM) for 12 h. Real-time PCR for NHE1 mRNA expression was performed in Neo, BI-1 and CDBI-1 cells (a) or NHE activity was measured (b). Neo, BI-1 and CDBI-1 cells were incubated with or without EIPA and NHE activity was measured (c). Neo, BI-1 and CDBI-1 cells were incubated with or without EIPA and intra-(left) and extracellular pH (right) were measured (d). In the presence or absence of EIPA (20 mM), infiltration (e) and wound healing assays (f) were performed. Neo, BI-1 and CDBI-1 cells were incubated with or without EIPA for the indicated periods and gelatin zymography was performed to quantify MMP2/9 activity (g). In the presence or absence of dimethyl amiloride (5 mM), infiltration (h) and wound healing assays (i) were performed. Measurements of intracellular and mitochondrial ATP Mitochondrial and total ATP levels were measured using an ATP assay kit (BioVision, Mountain View, CA, USA) according to the manufacturer's instructions. Luminescence was measured using a Wallace microplate luminescence reader (Perkin Elmer) and normalized to the protein concentration.
In particular, for the measurement of mitochondrial ATP, mitochondrial fractions (200 mg) were incubated for 20 min at 25 1C in EB buffer (125 mM KCl, 10 mM Tris-MOPS pH 7.4, 1 mM Pi, 5 mM glutamate, 2.5 mM malate and 10 mM EGTA). After centrifugation for 10 min at 15 000 g, the mitochondrial pellet was resuspended in ATP buffer (100 mM Tris-HCl, pH 7.9 and 4 mM EDTA), boiled for 2 min at 100 1C, and centrifuged for 2 min at 1000 g. The supernatant was mixed with the luciferase reagent, and the luminescence emission was measured at 562 nm. Results from three independent experiments were normalized to the control.
Measurement of Pyruvate dehydrogenase activity
To measure PDH activity, mitochondria (100 mg/ml) in 20 mM MOPS, 0.15% Triton, pH 7.4 were incubated with 200 mM thiamine pyrophosphate, 40 mM CoASH, 2.5 mM pyruvate, 5.0 mM MgCl 2 , 5.0 mM CaCl 2 and 1.0 mM NAD þ . PDH activity was measured at 25 1C as the rate of NADH production at 340 nm.
siRNA transfection The siRNAs were synthesized in duplex and purified forms using Bioneer Technology (Daejon, South Korea). The double-strand small interfering RNAs (siRNAs) targeting BI-1 (For BI-1 siRNA, 5-GUGGAAGGCCUUCUUUC UA-3 (forward) and 5-UAGAAAGAAGGCCUUCCAC-3 (reverse)) for nonspecific siRNA, CUGAACAACCAAUGCA AAU-3 (forward) and 5-AUUUGCAU UGGUUGUUCA G-3 (reverse) were transfected separately or together into Neo and BI-1 cells using Amaxa Nucleofector (Amaxa, Gaithersburg, MD, USA). Briefly, confluent cells were trypsinized and resuspended in Amaxa Nucleofector solution at 2 Â 10 5 cells per 100 ml of solution, and BI-1, or on-specific siRNA was added. Cells were transfected by electroporation using the A24 pulsing program.
Gelatin Zymography
Cells were cultured in serum-free DMEM medium, and the medium was collected and centrifuged at 3000 r.p.m. for 10 min to remove cell debris. The protein concentration was measured using BCA protein assay reagents (Pierce). Equal amounts of protein of conditioned media were mixed with 2 Â Laemmli nonreducing sample buffer, incubated for 15 min at room temperature, and then electrophoresed on 10% SDS-PAGE gels containing 1 mg/ml gelatin. After electrophoresis, the gels were washed with 2.5% Triton X-100 three times for 30 min, rinsed for 15 min with 50 mM Tris-HCl buffer (pH 7.6) containing 5 mM CaCl 2 , 0.02% Brij-35 and 0.2% sodium azide, and incubated overnight at 37 1C. The gels were stained with 0.5% Coomassie Brilliant Blue R-250 solution containing 10% acetic acid and 20% methanol for 30 min and destained with 10% acetic acid solution. Areas of gelatinase activity were detected as clear bands against the blue-stained gelatin background.
Intracellular pH Measurements
Cells were grown to subconfluency on glass slides. Individual slides were transferred to a heated perfusion chamber maintained at 37 1C on an inverted microscope (Zeiss Axiovert 200) and attached to a free-flow perfusion system. All solutions were kept at 37 1C using a feedback heating system. After mounting, cells were incubated for 15 min at 37 1C with a standard HEPES solution containing 10 mM pH-sensitive dye 2 0 -7 0 -bis(2-carboxyethyl)-5(6)-carboxyfluorescein (Molecular Probes, Eugene, OR, USA). Cells were then washed with HEPES to remove any non-de-esterified dye. After washing, cells were excited with 490 and 440 nm light, whereas the emission was monitored at 535 nm. The ratiometric emission of 490/440 was converted to intracellular pH after calibration using the high K þ /nigericin technique (Honegger et al., 2006) . In brief, after a 20 mM NH 4 Cl prepulse, cells were washed with a Na-free solution (HEPES buffer with NaCl replaced by N-methyl-D-glutamine). NHE activity was calculated from the initial slope of intracellular alkalization upon re-addition of Na. To allow for direct comparison, DpH per min was calculated only for intracellular pH values in the range of pH 6.50-6.80. All experiments were performed as paired experiments with measurement of NHE activity before and after a 15-min period of incubation. Control cells were incubated only with standard HEPES solution.
Real-time quantitative polymerase chain reaction NHE1 mRNA was quantified using TagMan probes. One microgram of cDNA, oligonucleotides at a final concentration of 800 nM of the primers and TaqMan hybridization probe (200 nM) were used in a total volume of 25 ml. The probe used for real-time polymerase chain reaction (RT-PCR) was labeled with carboxyfluoroscein (FAM) at the 5 0 -end and with a quencher carboxytetramethylrhodamine (TAMRA) at the 3 0 -end. PCR primer used for human NHE1 and TaqMan probes (P) were as follows: NHE1: F: 5 0 -ATGATGCGGAGCAAG GAGACT-3 0 , R: 5 0 -GTCACTGAGGCAGCGCTGTAT-3 0 , P: 5 0 -TCTTCACCCCCGCGCCCAT-3 0 Real-time RT-PCR was performed using a PE Biosystems ABI PRISM 7700 Sequence Detection System. The thermocycler parameters were 50 1C for 2 min and 95 1C for 10 min, followed by 40 cycles at 95 1C for 15 s and 60 1C for 1 min. All reactions were performed in triplicate.
Statistical analysis
Results are presented as mean±s.e.m of n cells, and paired and unpaired Student's t-tests were applied where appropriate. Microcal Origin software (Northampton, MA, USA) was used for statistical calculations. P-values were determined by w 2 -tests or Student's t-tests. Statistical significance was set at Po0.05.
